Skip to main content
. 2023 Aug 17;9(3):e003250. doi: 10.1136/rmdopen-2023-003250

Figure 2.

Figure 2

Presence of SLE treatments during the 6 months before the earliest COVID-19 diagnosis among patients with SLE with and without severe COVID-19. *Significantly different from patients without severe COVID-19 (p<0.05); voclosporin use was observed among two patients without severe COVID-19 (0.08%) and one patient with severe COVID-19 (0.2%). SLE, systemic lupus erythematosus.